Genitourinary Radiology: Page 37

Exact Imaging touts ExactVu clinical results

By AuntMinnie.com staff writers

Canadian microultrasound technology developer Exact Imaging is highlighting initial clinical results published in the Journal of Urology for its prostate risk identification microultrasound (PRI-MUS) protocol with its ExactVu platform.

July 27, 2016

Machine learning may aid evaluation of prostate MRI

By Erik L. Ridley

Multiparametric prostate MRI exams can be difficult to interpret, particularly for those who aren't expert genitourinary radiologists. Machine-learning software may be able to make that task a lot easier, however, according to a proof-of-concept study from the University of California, Los Angeles.

July 19, 2016

PET/MRI technique shows promise for prostate cancer

By Wayne Forrest

The combination of F-18 choline PET and multiparametric MRI shows promise for detecting prostate cancer, according to a study in the July issue of the Journal of Nuclear Medicine.

July 11, 2016

C4 touts MRI-guided prostate brachytherapy study

By AuntMinnie.com staff writers

Image-guided technology developer C4 Imaging said that a recent research study from MD Anderson Cancer Center in Houston showed positive results from using the company's Sirius MRI marker in MRI-guided prostate brachytherapy.

July 5, 2016

Blue Earth, PETNet roll out Axumin

By AuntMinnie.com staff writers

Radiopharmaceutical developer Blue Earth Diagnostics and Siemens Healthineers subsidiary PETNet Solutions said that Blue Earth's Axumin radiopharmaceutical for PET imaging of recurrent prostate cancer will be commercially available this month in the U.S.

June 6, 2016

Imaging takes leading role in penis transplant

By Eric Barnes

When Thomas Manning underwent one of the world's first successful penis transplant operations last month, imaging was there to guide the physician team with three separate modalities, according to doctors at Massachusetts General Hospital in Boston.

June 5, 2016

MRI technique aids prostate cancer detection

By AuntMinnie.com staff writers

A novel MR imaging technique known as restriction spectrum imaging (RSI) can accurately differentiate aggressive prostate cancer from low-grade or benign tumors, according to a study published in the June 1 issue of Clinical Cancer Research.

June 1, 2016

FDA approves Blue Earth PET agent for prostate cancer

By Brian Casey

The U.S. Food and Drug Administration (FDA) has approved a new PET radiopharmaceutical from Blue Earth Diagnostics for detecting recurrent prostate cancer.

May 26, 2016

New HIFU center launches in Ohio

By AuntMinnie.com staff writers

Central Ohio Urology Group and urology services provider AKSM have teamed up to launch an outpatient high-intensity focused ultrasound (HIFU) treatment service in Columbus, OH.

May 9, 2016

Signostics gets FDA clearance for urologic ultrasound

By AuntMinnie.com staff writers

Handheld ultrasound provider Signostics said it has received U.S. Food and Drug Administration (FDA) clearance for its Uscan ultrasound visualization device for urology. The company will showcase the product at this week's American Urological Association meeting in San Diego.

May 5, 2016

Trial: Catheter device cuts contrast use

By AuntMinnie.com staff writers

A catheter-based device designed to reduce contrast media use was found to cut dose by more than 15% in interventional cardiac procedures, according to trial results presented on Wednesday at the Society for Cardiovascular Angiography and Interventions scientific sessions.

May 4, 2016

3D MRI technique depicts postablation prostate changes

By Eric Barnes

A new MRI-based 3D software technique is able to capture and quantify changes to the prostate after focal laser ablation therapy, researchers reported April 18 in PLOS One. The software could provide better management of prostate cancer patients after laser ablation therapy.

May 1, 2016

Previous Page

Page 37 of 93

Next Page